Alembic Pharmaceuticals Limited has successfully completed the Brazilian Health Regulatory Agency GMP audit at API-III Facility at Karakhadi without any observations for its 56 APIs.
Alembic Pharmaceuticals Limited has successfully completed the United States Food and Drug Administration inspection for its Derma Facility located at Karakhadi without any observations.
The Board of Directors of Alembic Pharmaceuticals Limited, at its meeting held today have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23 and 9MFY23.